Annual Statement of Changes in Beneficial Ownership (5)

FORM 5

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ] Form 3 Holdings Reported
[ X ] Form 4 Transactions Reported

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0362
Estimated average burden
hours per response... 1.0

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^* Belldegrun Arie	2. Issuer Name and Ticker or Trading Symbol Arno Therapeutics, Inc [ARNI]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle) C/O ARNO THERAPEUTICS, INC., 200 ROUTE 31 NORTH, SUITE 104	3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY) 12/31/2014
(Street) FLEMINGTON, NJ 08822 (City) (State) (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form Filed by One Reporting Person ___ Form Filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)	4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock							3115	D
Common Stock							143809	I	Leumi Overseas Trust Corp. Ltd as TTEE of the BTL Trust ⁽¹⁾
Common Stock							254887	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ⁽²⁾
Common Stock							379294	I	Belldegrun Family Trust ⁽³⁾
Common Stock							174644	I	MDRB Partnership, L.P. ⁽⁴⁾
Common Stock							100481	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ⁽⁵⁾

*Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (MM/DD/YYYY)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)			11. Nature of Indirect Beneficial Ownership (Instr. 4)
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		104166	10/29/2013	10/31/2014	Common Stock	104166	$0	0	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	104166		10/29/2013	1/31/2015	Common Stock	104166	$0	104166	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the BTL Trust ⁽¹⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		125000	10/29/2013	10/31/2014	Common Stock	125000	$0	0	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ⁽²⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	125000		10/29/2013	1/31/2015	Common Stock	125000	$0	125000	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ⁽¹⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		104166	10/29/2013	10/31/2014	Common Stock	104166	$0	0	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ⁽²⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	104166		10/29/2013	1/31/2015	Common Stock	104166	$0	104166	I	Leumi Overseas Trust Corp. Ltd. as TTEE of the Tampere Trust ⁽²⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		145833	10/29/2013	10/31/2014	Common Stock	145833	$0	0	I	Belldegrun Family Trust ⁽³⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	145833		10/29/2013	1/31/2015	Common Stock	145833	$0	145833	I	Belldegrun Family Trust ⁽³⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		187500	10/29/2013	10/31/2014	Common Stock	187500	$0	0	I	Belldegrun Family Trust ⁽³⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	187500		10/29/2013	1/31/2015	Common Stock	187500	$0	187500	I	Belldegrun Family Trust ⁽³⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		62500	10/29/2013	10/31/2014	Common Stock	62500	$0	0	I	MDRB Partnership, L.P. ⁽⁴⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	62500		10/29/2013	1/31/2015	Common Stock	62500	$0	62500	I	MDRB Partnership, L.P. ⁽⁴⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		83333	10/29/2013	10/31/2014	Common Stock	83333	$0	0	I	MDRB Partnership, L.P. ⁽⁴⁾
2013 Series E Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	83333		10/29/2013	1/31/2015	Common Stock	83333	$0	83333	I	MDRB Partnership, L.P. ⁽⁴⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		D4 ⁽⁶⁾		83333	10/29/2013	10/31/2014	Common Stock	83333	$0	0	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ⁽⁵⁾
2012 Series B Warrants (right to buy)	$2.40	10/28/2014		A4 ⁽⁶⁾	83333		10/29/2013	1/31/2015	Common Stock	83333	$0	83333	I	Arie S. Belldegrun, M.D. Inc. Profit Sharing Plan ⁽⁵⁾

Explanation of Responses:
( 1)	Although the Reporting Person is not a trustee of the BTL Trust, the Reporting Person is a beneficiary of the BTL Trust, and as such may be deemed to be the beneficial owner of the securities owned by the BTL Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
( 2)	Although the Reporting Person is not a trustee of the Tampere Trust, the Reporting Person is a beneficiary of the Tampere Trust, and as such may be deemed to be the beneficial owner of the securities owned by the Tampere Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
( 3)	The Reporting Person is the trustee of the family trust that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
( 4)	The Reporting Person is the managing partner of the limited partnership that owns the securities. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
( 5)	The Reporting Person is the trustee of the profit sharing plan that owns the securities.
( 6)	The two reported transactions resulted from the Issuer's unilateral extension of the expiration date of two outstanding warrants from 10/31/14 to 1/31/15. Such extension resulted in the deemed cancellation of the "originally" issued old warrant and the issuance of a replacement warrant. The Series B warrant was originally granted on 11/26/12 and the Series E warrant was originally granted on 10/29/13.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Belldegrun Arie C/O ARNO THERAPEUTICS, INC. 200 ROUTE 31 NORTH, SUITE 104 FLEMINGTON, NJ 08822	X

Signatures
/s/ Christopher J. Melsha as Attorney-in-Fact for Arie S. Belldegrun pursuant to a Power of Attorney previously filed.		2/17/2015
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.